Literature DB >> 29164400

Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.

Fabricio Q Silva1, Francisco J A Santos1, Andreia P Andrade1, Suzy D B Pacheco1, Benedikt Fischer2,3, João Renato R Pinho4, José Alexandre R Lemos5, Aldemir B Oliveira-Filho6.   

Abstract

Hepatitis C virus (HCV) infection causes acute and chronic liver disease and may lead to cirrhosis, liver failure or hepatocellular carcinoma. The behavior of illicit drug users (DUs) typically exposes them to risks of viral infection. In the Brazilian Amazon region, a number of studies have identified high rates of drug use among adolescents, and a high prevalence of HBV infection in DUs, disseminated by sexual and parenteral activities. However, the epidemiological scenario of HCV infection in the region is still poorly understood. This study determined the prevalence, genotypes, and risk factors for HCV infection among DUs of the Marajó Archipelago. This cross-sectional study collected samples and epidemiological information from DUs in 11 municipalities. The diagnosis was established by EIA and real-time PCR, and the samples were genotyped by multiplex real time PCR. The data were analyzed by simple and multiple logistical regression. In 466 DUs, 28.3% had anti-HCV antibodies, and 25.5% had HCV-RNA. In 92 injecting drug users, 88.0% had anti-HCV antibodies, and 80.4% had HCV-RNA. Genotypes 1 and 3 were detected, with three cases of mixed infections. The multivariate analysis indicated associations of HCV infection with age (≥ 35 years), tattoos, intravenous drug use, shared use of injection equipment, and the daily and long-term (> 3 years) use of illicit drugs. These findings will contribute to the development of effective measures for the prevention of HCV infection among Brazilian DUs, as well as its general population.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29164400     DOI: 10.1007/s00705-017-3656-y

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  4 in total

1.  Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.

Authors:  Siyan Yi; Phalkun Mun; Pheak Chhoun; Navy Chann; Sovannary Tuot; Gitau Mburu
Journal:  Harm Reduct J       Date:  2019-04-29

2.  Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil.

Authors:  Aldemir B Oliveira-Filho; Ana Paula S Araújo; Andreia Polliana C Souza; Camila M Gomes; Gláucia C Silva-Oliveira; Luísa C Martins; Benedikt Fischer; Luiz Fernando A Machado; Antonio Carlos R Vallinoto; Ricardo Ishak; José Alexandre R Lemos; Emil Kupek
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

3.  Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region.

Authors:  Aldemir B Oliveira-Filho; Diego Wendel F Aires; Natalia S Cavalcante; Nairis Costa Raiol; Brenda Luena A Lisboa; Paula Cristina R Frade; Luana M da Costa; Luiz Marcelo L Pinheiro; Luiz Fernando A Machado; Luisa C Martins; Gláucia C Silva-Oliveira; João Renato R Pinho; Emil Kupek; José Alexandre R Lemos
Journal:  Pathogens       Date:  2019-11-14

4.  Treponema pallidum in female sex workers from the Brazilian Marajó Archipelago: prevalence, risk factors, drug-resistant mutations and coinfections.

Authors:  Evelen C Coelho; Samara B Souza; Camila Carla S Costa; Luana M Costa; Luiz Marcelo L Pinheiro; Luiz Fernando A Machado; Gláucia C Silva-Oliveira; Luísa Caricio Martins; Paula Cristina R Frade; Aldemir B Oliveira-Filho
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-07-01       Impact factor: 2.184

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.